Nitrostat - (0.3,0.4,0.6 mg; Tablet, Sublingual)

Generic Name	Nitroglycerin	Innovator	Pfizer
Dosage	0.3,0.4,0.6 mg; Tablet, Sublingual	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	More Than 5	Generic Launches	Less Than 5
Indication	Used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease).
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
***********	*** \ **	*** *********	*** *********	******** ************	*** ** ******
** *****'*	** \ **	*** *********	*** *********	********	******** ** *** **, ****
********	** \ **	*** *********	*** *********	********	******** ** *** **, ****

Chronology Of Events